| PERIOD ENDING | 31-Jul-09 | 31-Jul-08 | 31-Jul-07 | | Total Revenue | 1,119 | 128 | 180 | | Cost of Revenue | 528 | 55 | 62 | | | Gross Profit | 591 | 73 | 119 | | | Operating Expenses | | Research Development | 13,562 | 16,359 | 11,984 | | Selling General and Administrative | 13,285 | 17,159 | 13,011 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (26,256) | (33,445) | (24,876) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 559 | 1,497 | 2,221 | | Earnings Before Interest And Taxes | (25,698) | (31,948) | (22,655) | | Interest Expense | 20,115 | 4,281 | 850 | | Income Before Tax | (45,812) | (36,229) | (23,505) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (45,812) | (36,229) | (23,505) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (45,812) | (36,229) | (23,505) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($45,812) | ($36,229) | ($23,505) |
|
0.29% Nasdaq 
0.011 (2.20%) 
Income Statement
